| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
|
Felip, Enriqueta
|
|
|
192 |
C |
p.
|
artikel
|
| 2 |
Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer
|
Ke, Helen
|
|
|
192 |
C |
p.
|
artikel
|
| 3 |
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study
|
Huang, Zhe
|
|
|
192 |
C |
p.
|
artikel
|
| 4 |
Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern
|
Goto, Eisuke
|
|
|
192 |
C |
p.
|
artikel
|
| 5 |
Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients
|
Klotz, Laura V.
|
|
|
192 |
C |
p.
|
artikel
|
| 6 |
Contents
|
|
|
|
192 |
C |
p.
|
artikel
|
| 7 |
Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma
|
Szentkereszty, Márton
|
|
|
192 |
C |
p.
|
artikel
|
| 8 |
DNA double-strand break repair capacity and its pathway gene variants predict the risk and prognosis of lung cancer
|
Peng, Li
|
|
|
192 |
C |
p.
|
artikel
|
| 9 |
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence
|
Nadal, Ernest
|
|
|
192 |
C |
p.
|
artikel
|
| 10 |
EGFR-mutant NSCLC may remodel TME from non-inflamed to inflamed through acquiring resistance to EGFR-TKI treatment
|
Chen, Qianqian
|
|
|
192 |
C |
p.
|
artikel
|
| 11 |
Endocrine immune-related adverse event is a prognostic biomarker independent of lead-time bias
|
Ishidoya, Mina
|
|
|
192 |
C |
p.
|
artikel
|
| 12 |
Image guided lung biopsy
|
Shah, R
|
|
|
192 |
C |
p.
|
artikel
|
| 13 |
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial
|
Iihara, Hirotoshi
|
|
|
192 |
C |
p.
|
artikel
|
| 14 |
Mutational analysis of pulmonary large cell neuroendocrine carcinoma: APC gene mutations identify a good prognostic factor
|
Li, Mengqian
|
|
|
192 |
C |
p.
|
artikel
|
| 15 |
Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study
|
Voruganti Maddali, Indu S.
|
|
|
192 |
C |
p.
|
artikel
|
| 16 |
Palliative care integration and end-of-life care intensity for patients with NSCLC
|
Martin, A.
|
|
|
192 |
C |
p.
|
artikel
|
| 17 |
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods
|
Shi, Mengting
|
|
|
192 |
C |
p.
|
artikel
|
| 18 |
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort
|
Li, Y.
|
|
|
192 |
C |
p.
|
artikel
|
| 19 |
The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma
|
Wang, Zhen
|
|
|
192 |
C |
p.
|
artikel
|
| 20 |
Trends in lung cancer survival in the Nordic countries 1990–2016: The NORDCAN survival studies
|
Lundberg, Frida E.
|
|
|
192 |
C |
p.
|
artikel
|
Tijdschrift beschrijving